Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Drainage of Cells and Soluble Antigen from the CNS to Regional Lymph Nodes.
Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis.
Multiple sclerosis: the role of cytokines in pathogenesis and in therapies.
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK.
Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation.
Reducing survey burden: feasibility and validity of PROMIS measures in multiple sclerosis.
Therapeutic satisfaction and subjective effects of different strains of pharmaceutical-grade cannabis.
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity.
Neuropathic Pain in Multiple Sclerosis Improved With Oral Famciclovir: A Case Report.
Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case-control studies.
Use and acceptance of electronic communication by patients with multiple sclerosis: a multicenter questionnaire study.
Body mass index and waist circumference in persons aging with muscular dystrophy, multiple sclerosis, post-polio syndrome, and spinal cord injury.
Acquired immune demyelinating neuropathies.
Update on Disease-Modifying Treatments for Multiple Sclerosis.
Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease.
Differences in oligoclonal bands and visual evoked potentials in patients with radiologically and clinically isolated syndrome.
Acute demyelinating encephalomyelitis in a child following malaria.
Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
Up-Regulation of Excitatory Amino Acid Transporters EAAT1 and EAAT2 by ß-Klotho.
Editorial comment.
Platelets and autoimmunity.
Connexin astrocytopathy and novel therapeutic strategy targeting connexin hemichannels in demyelinating disease.
Perception of affective prosody in patients at an early stage of relapsing-remitting multiple sclerosis.
Driving competences and neuropsychological factors associated to driving counseling in multiple sclerosis.
Multiple sclerosis: from molecules to treatment.
Pages
« first
‹ previous
…
297
298
299
300
301
302
303
304
305
…
next ›
last »